Japanese Pharmaceuticals & Biotech Low Leverage High Rewards

Ono Pharmaceutical

Market Cap: JP¥771.3b

Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Linical

Market Cap: JP¥6.7b

Provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide.

Santen Pharmaceutical

Market Cap: JP¥486.7b

Engages in the research and development, manufacture, and marketing of pharmaceuticals and medical devices in Japan and internationally.

Shionogi

Market Cap: JP¥2.0t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Kaken Pharmaceutical

Market Cap: JP¥153.9b

Produces, markets, and sells medical products, medical devices, and agrochemicals in Japan and internationally.

Sawai Group Holdings

Market Cap: JP¥236.6b

Together with subsidiaries, engages in the research and development, manufacturing, and marketing of generic pharmaceuticals.

Eisai

Market Cap: JP¥1.2t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Kissei Pharmaceutical

Market Cap: JP¥160.3b

Researches, develops, manufactures, and sells pharmaceutical products primarily in Japan.

Hisamitsu Pharmaceutical

Market Cap: JP¥316.1b

Manufactures and sells pharmaceuticals in Japan.

Nippon Shinyaku

Market Cap: JP¥247.8b

Manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally.

Kyowa Kirin

Market Cap: JP¥1.2t

Engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally.

Tsumura

Market Cap: JP¥324.8b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Seikagaku

Market Cap: JP¥38.7b

Manufactures and sells pharmaceuticals and medical devices primarily related to glycoconjugates in Japan and internationally.The company operates in two segments, Pharmaceuticals and LAL Business.

Daito PharmaceuticalLtd

Market Cap: JP¥31.4b

Manufactures and sells pharmaceutical products worldwide.

ASKA Pharmaceutical HoldingsLtd

Market Cap: JP¥65.9b

Through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan.

Mochida Pharmaceutical

Market Cap: JP¥109.5b

Manufactures and sells pharmaceuticals and healthcare products in Japan.